AeroLeads people directory · profile

Gerald Kovacs, Ph.D. Email & Phone Number

Pharmaceutical Consultant at Tunnell Government Services, Inc.
Location: Washington DC-Baltimore Area, United States, United States 9 work roles 3 schools
1 work email found @juno.com LinkedIn matched
✓ Verified May 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email g****@juno.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Role
Pharmaceutical Consultant
Location
Washington DC-Baltimore Area, United States, United States
Company size

Who is Gerald Kovacs, Ph.D.? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Gerald Kovacs, Ph.D. is listed as Pharmaceutical Consultant at Tunnell Government Services, Inc., a company with 67 employees, based in Washington DC-Baltimore Area, United States, United States. AeroLeads shows a work email signal at juno.com and a matched LinkedIn profile for Gerald Kovacs, Ph.D..

Gerald Kovacs, Ph.D. previously worked as Senior Advisor at Tunnell Government Services, Inc. and Founder and President at Kovax Pharma Group, Llc. Gerald Kovacs, Ph.D. holds Ph.D., Biochemistry And Biophysics from Texas A&M University.

Company email context

Email format at Tunnell Government Services, Inc.

This section adds company-level context without repeating Gerald Kovacs, Ph.D.'s masked contact details.

*@juno.com
68% confidence

AeroLeads found 1 current-domain work email signal for Gerald Kovacs, Ph.D.. Compare company email patterns before reaching out.

Profile bio

About Gerald Kovacs, Ph.D.

Dr. Kovacs possesses over 20 years of experience in pharmaceutical product development with expertise in vaccines and biopharmaceuticals. In his current role, Dr. Kovacs provides strategic guidance across BARDA's portfolio of vaccines to address COVID-19, Pandemic Influenza, emerging infectious diseases and Chemical, Biological, Nuclear, and Radiological (CBRN) threats. Previously, he served as Director in the HHS Biomedical Advanced Research and Development Authority (BARDA) office. He was responsible for BARDA’s portfolio of drugs, vaccines, and diagnostics against the major CBRN threats impacting the health security of the United States. He built and managed a portfolio estimated at $6 billion, with over 80 candidate products spanning all phases of clinical development. He was responsible for the approval of raxibacumab (anthrax monoclonal antibody therapeutic) and BAT (botulism antitoxin) – the first two products licensed through the FDA Animal Rule. He delivered eight products to the US Strategic National Stockpile for use in the event of national emergencies. For his service to the Nation, he received the prestigious HHS Secretary’s Award for Distinguished Service two times.Prior to joining public service, Dr. Kovacs worked at Wyeth where he developed pediatric and adult vaccines against influenza, respiratory syncytial virus, parainfluenza virus, human papilloma virus, and herpes simplex virus. He was responsible for all aspects of early vaccine development including R&D, innovation, technology transfer, preclinical testing, upstream and downstream process development, GMP manufacturing, analytical development, formulation, IND filing, project management, outsource management, and finance.

Listed skills include Vaccines, Infectious Diseases, Molecular Biology, Drug Development, and 38 others.

Current workplace

Gerald Kovacs, Ph.D.'s current company

Company context helps verify the profile and gives searchers a useful next step.

Tunnell Government Services, Inc.
Tunnell Government Services, Inc.
Pharmaceutical Consultant
bethesda, maryland, united states
Website
Employees
67
AeroLeads page
9 roles · 35 years

Gerald Kovacs, Ph.D. work experience

A career timeline built from the work history available for this profile.

Senior Advisor

Current

Washington D.C. Metro Area

Dr. Kovacs serves as senior advisor to BARDA in a strategic capacity; providing technical guidance regarding the manufacturing, testing, clinical, non-clinical, regulatory, and quality aspects of medical countermeasure advanced development and acquisition programs. His primary focus is currently in support of the COVID-19 and other emerging infectious.

Feb 2018 - Present

Founder And President

Kovax Pharma Group, Llc

Potomac, Maryland

KoVax Pharma Group, LLC is dedicated to working with vaccine developers in biotech companies, large Pharma and government. Consultations on strategic planning, regulatory strategies, preclinical development, analytical testing and manufacturing are provided. Our focus is on getting to proof-of-concept quickly and efficiently in the development process.

Jun 2016 - Oct 2021

Senior Advisor

Washington D.C. Metro Area

Dr. Kovacs served as senior advisor to BARDA in a strategic capacity; providing technical guidance regarding the manufacturing, testing, clinical, non-clinical, regulatory, and quality aspects of medical countermeasure advanced development and acquisition programs. His primary focus was in support of the Zika and H7N9 responses.

Apr 2016 - Jan 2018

Scientific Director

Advanced Bioscience Laboratories, Subsidiary Of The Institut Merieux

Rockville, MD

Advanced BioScience Laboratories, Inc (ABL) is a subsidiary of the Institut Merieux, and a leading contract research and manufacturing organization, partnering with its clients to advance their vaccine and therapeutic development programs through a unique combination of customized preclinical, clinical, and contract manufacturing services. Dr. Kovacs was.

Oct 2013 - Mar 2016

Director, Barda, Division Of Chemical, Biological, Radiological, And Nuclear Countermeasures

Washington D.C. Metro Area

The Biomedical Research and Development Authority (BARDA) develops and procures medical countermeasures, including vaccines, therapeutics, diagnostics, and non-pharmaceutical countermeasures, against a broad array of public health threats – whether natural or intentional in origin. Dr. Kovacs was responsible for the development, implementation, and.

Sep 2005 - Oct 2013

Sr. Program Manager

Bethesda, MD

The Office of Biodefense Research Affairs (OBRA) within the National Institute for Allergy and Infectious Diseases sets research priorities and funds extramural biodefense research, analyzes biodefense research needs, and maintains surveillance over developments in basic research, diagnostics, drug discovery, vaccine development, and clinical research. Dr..

2003 - 2005 ~2 yrs

Principal Research Scientist

Pearl River, NY

Pfizer (formerly Wyeth), applies science and global resources to develop vaccines that significantly improved people’s lives. Wyeth's portfolio included vaccines for pediatric, adult, and geriatric sectors of the population. Dr. Kovacs was responsible for the development of novel vaccine delivery systems. He was study director for herpes simplex virus.

1996 - 2003 ~7 yrs

National Research Council Fellow

Washington D.C. Metro Area

The Laboratory of Viral Diseases carries out investigations on the molecular biology of viruses, the interactions of viruses with host cells, the pathogenesis of viral diseases, and host defense mechanisms. The studies are designed to increase fundamental knowledge as well as to facilitate the development of new approaches to the prevention and treatment.

1992 - 1996 ~4 yrs

Post-Doctoral Research Fellow

Greater Boston Area

The Knipe laboratory studies the molecular and cellular biology of herpes simplex virus (HSV) productive and latent infections, and the mechanism of the host immune response to HSV. Dr. Kovacs conducted studies in HSV gene transcription and its effect on DNA replication.

1991 - 1992 ~1 yr
Team & coworkers

Colleagues at Tunnell Government Services, Inc.

Other employees you can reach at tunnellgov.com. View company contacts for 67 employees →

3 education records

Gerald Kovacs, Ph.D. education

Ph.D., Biochemistry And Biophysics

The Summers lab studied the molecular and cellular mechanisms of insect viral gene expression in their respective hosts and in vitro. The.

Leadership For A Democratic Society

Federal Executive Institute
FAQ

Frequently asked questions about Gerald Kovacs, Ph.D.

Quick answers generated from the profile data available on this page.

What company does Gerald Kovacs, Ph.D. work for?

Gerald Kovacs, Ph.D. works for Tunnell Government Services, Inc..

What is Gerald Kovacs, Ph.D.'s role at Tunnell Government Services, Inc.?

Gerald Kovacs, Ph.D. is listed as Pharmaceutical Consultant at Tunnell Government Services, Inc..

What is Gerald Kovacs, Ph.D.'s email address?

AeroLeads has found 1 work email signal at @juno.com for Gerald Kovacs, Ph.D. at Tunnell Government Services, Inc..

Where is Gerald Kovacs, Ph.D. based?

Gerald Kovacs, Ph.D. is based in Washington DC-Baltimore Area, United States, United States while working with Tunnell Government Services, Inc..

What companies has Gerald Kovacs, Ph.D. worked for?

Gerald Kovacs, Ph.D. has worked for Tunnell Government Services, Inc., Kovax Pharma Group, Llc, Conceptual Mindworks, Inc., Advanced Bioscience Laboratories, Subsidiary Of The Institut Merieux, and Department Of Health And Human Services.

Who are Gerald Kovacs, Ph.D.'s colleagues at Tunnell Government Services, Inc.?

Gerald Kovacs, Ph.D.'s colleagues at Tunnell Government Services, Inc. include Peter Wallace, Bryan Woolsey, Xiaomi Tong, Zun Thu Rain Tun, and Julie Dyall.

How can I contact Gerald Kovacs, Ph.D.?

You can use AeroLeads to view verified contact signals for Gerald Kovacs, Ph.D. at Tunnell Government Services, Inc., including work email, phone, and LinkedIn data when available.

What schools did Gerald Kovacs, Ph.D. attend?

Gerald Kovacs, Ph.D. holds Ph.D., Biochemistry And Biophysics from Texas A&M University.

What skills is Gerald Kovacs, Ph.D. known for?

Gerald Kovacs, Ph.D. is listed with skills including Vaccines, Infectious Diseases, Molecular Biology, Drug Development, Clinical Development, Biotechnology, Immunology, and Life Sciences.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.